Skip to content
akaturk Academic measurement
2025 SJR Q1 JCR Q4 · 0,3 ESCI

Journal detail

GaBI Journal

Publisher
Pro Pharma Communications International
Country
Belgium · Western Europe
Type
journal
ISSN
  • 20336403
  • 20336772
Scopus 0,224 SJR
Scopus Q1 SJR Q
WoS Q4 JCR Q
WoS 0,3 JIF
Scopus 16 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,224
  • Quartile Q1
  • H-Index 16
  • Cites/doc 0,36
  • Docs (3y) 72
  • Cites (3y) 28

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q4
  • JIF 0,3
  • 5Y JIF 0,4
  • JCI 0,05

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Drug Guides Q1
  • Pharmacy Q3

Areas

  • Health Professions
  • Medicine

WoS categories

  • Pharmacology & Pharmacy

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q1 Q4 0,224 0,3 0,4 0,05 Q4 16
2024 Q3 Q4 0,15 0,2 0,5 0,07 Q4 16
2023 Q3 Q4 0,163 0,3 0,6 0,2 Q4 16
2022 Q3 0,174 0,5 0,7 0,27 Q4 16
2021 Q3 0,153 16
2020 Q2 0,217 0,38 Q4 16
2019 Q2 0,167 16
2017 Q1 0,479 16
2016 Q1 0,399 16
2015 Q1 0,413 16
2014 16

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 PHARMACOLOGY & PHARMACY ESCI Q4 Q4 351/356
2024 PHARMACOLOGY & PHARMACY ESCI Q4 Q4 345/352
2023 PHARMACOLOGY & PHARMACY ESCI Q4 Q4 344/354
2022 PHARMACOLOGY & PHARMACY ESCI Q4
2020 PHARMACOLOGY & PHARMACY ESCI Q4